Kousuke Noguchi
Overview
Explore the profile of Kousuke Noguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
57
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wada K, Watanabe M, Shinchi M, Noguchi K, Mukoyoshi T, Matsuyama M, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi
. 2021 Aug;
77(8):787-794.
PMID: 34421066
Purpose: Radiation dermatitis is one of the most common adverse events in patients undergoing radiotherapy. However, the objective evaluation of this condition is difficult to provide because the clinical evaluation...
2.
Prabhu A, Brandl A, Wakama S, Sako S, Ishibashi H, Mizumoto A, et al.
Cancers (Basel)
. 2020 Sep;
12(9).
PMID: 32906609
Signet ring cell subtype (SRC) of colorectal cancer (CRC) is a rare subtype and occurs in approximately 1% of all patients with CRC. Patients with peritoneal metastasis (PM) of SRC...
3.
Prabhu A, Brandl A, Wakama S, Sako S, Ishibashi H, Mizumoto A, et al.
Cancers (Basel)
. 2020 Aug;
12(8).
PMID: 32784670
Neoadjuvant intravenous chemotherapy in patients with pseudomyxoma peritonei (PMP) has not shown convincing results. The effectiveness of neoadjuvant intraperitoneal (IP) chemotherapy has never been reported. This prospective, non-randomized phase II...
4.
Goto Y, Mizumoto A, Hirano M, Takao N, Ichinose M, Noguchi K, et al.
Int Cancer Conf J
. 2019 Jun;
6(4):188-192.
PMID: 31149500
Ovarian growing teratoma syndrome (GTS) is a rare disease characterized by growth of a benign tumor during or after chemotherapy, following the removal of germ cell gonadal cancers. Although benign,...
5.
Yonemura Y, Canbay E, Wakama S, Sako S, Ishibashi H, Hirano M, et al.
Gan To Kagaku Ryoho
. 2019 Mar;
46(2):395-399.
PMID: 30914572
Background And Objectives: The current standard of treatment for malignant peritoneal mesothelioma(MPM)is cytoreductive surgery(CRS)plus perioperative intraperitoneal or systemic chemotherapy(comprehensive treatment), The present study was performed to clarify the prognostic factors...
6.
Yonemura Y, Canbay E, Wakama S, Sako S, Ishibashi H, Hirano M, et al.
Gan To Kagaku Ryoho
. 2019 Mar;
46(2):251-258.
PMID: 30914528
Background And Objectives: Treatment failure after complete cytoreduction for appendiceal mucinous carcinoma peritonei (AMCP)has not been fully investigated. The present study was performed to clarify the risk factor for recurrence...
7.
Yonemura Y, Sako S, Wakama S, Ishibashi H, Mizumoto A, Takao N, et al.
Indian J Surg Oncol
. 2019 Mar;
10(Suppl 1):3-11.
PMID: 30886486
In this review, Japanese experience of cytoreductive surgery and perioperative chemotherapy is described. The new concept of peritoneal metastasis (PM) type, i.e., trans-mesothelial, trans-lymphatic, and superficial growing metastasis type was...
8.
Yonemura Y, Canbay E, Sako S, Wakama S, Ishibashi H, Hirano M, et al.
Gan To Kagaku Ryoho
. 2018 Feb;
44(12):1939-1942.
PMID: 29394827
To analyze the role of cytoreductive surgery(CRS)plus perioperative chemotherapy on the survival of colorectal cancer(CRC)patients with metachronous peritoneal metastasis(PM). A comprehensive treatment consisting of neoadjuvant chemotherapy plus CRS was performed...
9.
Yonemura Y, Endo Y, Canbay E, Liu Y, Ishibashi H, Mizumoto A, et al.
Cancers (Basel)
. 2017 Mar;
9(3).
PMID: 28257041
In the past, peritoneal metastasis (PM) was considered as a terminal stage of cancer. From the early 1990s, however, a new comprehensive treatment consisting of cytoreductive surgery and perioperative chemotherapy...
10.
Yonemura Y, Canbay E, Shintani H, Yoshitake H, Hatano K, Sako S, et al.
Gan To Kagaku Ryoho
. 2017 Jan;
43(12):1435-1439.
PMID: 28133015
Materials And Methods: A total of 205 patients with CRC who underwent complete cytoreductive surgery combined with perioperative chemotherapy were investigated. Results: Recurrence occurred in 149(73%)patients. The 5-year overall and...